Organogenesis Holdings (ORGO) Assets Average (2016 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Assets Average of $559.4 million for Q1 2026, up 15.9% year-over-year from $482.6 million in Q1 2025, and up 0.92% quarter-over-quarter from $554.3 million in Q4 2025.
Organogenesis Holdings (ORGO) Assets Average (2016 - 2026) Analysis & Trends
Organogenesis Holdings' Assets Average history runs 11 years deep, the most recent figure standing at $559.4 million for Q1 2026.
- In Q1 2026, Assets Average rose 15.9% year-over-year to $559.4 million; the TTM figure through Mar 2026 stood at $559.4 million (up 15.9% YoY), while the FY2025 annual figure was $548.3 million, up 14.48% from the prior year.
- Assets Average for Q1 2026 stood at $559.4 million, up from $554.3 million in the prior quarter.
- The five-year high for Assets Average was $559.4 million in Q1 2026, with the low at $439.8 million in Q1 2022.
- The 5-year median for Assets Average is $456.8 million (2022), against an average of $469.6 million.
- The sharpest annual moves came in 2022 and 2024: Assets Average surged 44.33% in 2022, then declined 2.57% in 2024.
- Organogenesis Holdings' Assets Average stood at $453.3 million in 2022, then grew by 1.77% to $461.3 million in 2023, then gained by 2.33% to $472.1 million in 2024, then rose by 17.41% to $554.3 million in 2025, then grew by 0.92% to $559.4 million in 2026.
- Business Quant data shows ORGO's Assets Average at $559.4 million in Q1 2026, $554.3 million in Q4 2025, and $485.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | Organogenesis Holdings | 239.98 Mn | 193.13 Mn | 20.08 Mn | 463.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 463.22 Mn |
| Mar 31, 2026 | 559.36 Mn |
| Dec 31, 2025 | 554.28 Mn |
| Sep 30, 2025 | 485.48 Mn |
| Jun 30, 2025 | 464.26 Mn |
| Mar 31, 2025 | 482.64 Mn |
| Dec 31, 2024 | 472.09 Mn |
| Sep 30, 2024 | 444.73 Mn |
| Jun 30, 2024 | 450.82 Mn |
| Mar 31, 2024 | 459.25 Mn |
| Dec 31, 2023 | 461.34 Mn |
| Sep 30, 2023 | 456.48 Mn |
| Jun 30, 2023 | 448.21 Mn |
| Mar 31, 2023 | 447.73 Mn |
| Dec 31, 2022 | 453.32 Mn |
| Sep 30, 2022 | 456.81 Mn |
| Jun 30, 2022 | 446.31 Mn |
| Mar 31, 2022 | 439.77 Mn |
| Dec 31, 2021 | 406.84 Mn |
| Sep 30, 2021 | 362.99 Mn |